A structured diagnostic designed to assess commercialization discipline and identify risk across assortment, pricing, and launch readiness.
This diagnostic is typically used to:
Surface gaps in decision-making and governance
Identify sources of margin erosion and execution risk
Create visibility into where commercialization breaks down as businesses scale
Outcome:
Clear, objective insight into commercialization risks and priorities before deeper intervention.
A structured diagnostic designed to assess commercialization discipline and identify risk across assortment, pricing, and launch readiness.
This diagnostic is typically used to:
Surface gaps in decision-making and governance
Identify sources of margin erosion and execution risk
Create visibility into where commercialization breaks down as businesses scale
Outcome:
Clear, objective insight into commercialization risks and priorities before deeper intervention.